Synexus Clinical Research Limited
05575991
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
- Loss before tax (-10)
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Previously known as
Compliance
Last accounts
31/12/2024
full
Next accounts due
30/09/2026
Confirmation statement
Last: 23/06/2026
Due 07/07/2027
Industry
Officers
Former
director · Resigned 31/05/2016
director · Resigned 31/05/2016
director · Resigned 10/10/2017
director · Resigned 13/09/2019
director · Resigned 13/09/2019
director · Resigned 19/03/2020
director · Resigned 30/06/2020
director · Resigned 30/06/2021
director · Resigned 30/06/2021
director · Resigned 31/01/2023
director · Resigned 29/03/2023
director · Resigned 29/03/2023
director · Resigned 24/05/2023
director · Resigned 18/04/2024
secretary · Resigned 31/03/2026
Persons with Significant Control
Synexus Clinical Research Midco No 1 Limited
12b Granta Park, Great Abington, Cambridge, CB21 6GQ
Reg: 09389074 · Companies House · Limited By Shares
Notified 31/08/2016
Former PSCs
Synexus Clinical Research Acquisitions Limited
Ceased 31/08/2016
Change History
Active
Private Limited Company
12B GRANTA PARK
CAMBRIDGE
CompanyRankvs 34469+ SIC 74909 peers41
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company ’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going c
Key FinancialsYear ending 31/12/2022
Turnover
£76.4M
Annual revenue
Net Worth
-£12.1M
Balance sheet strength
Cash
£37.2M
Cash in the bank
Profit Before Tax
-£8.8M
Bottom line earnings
Net Current Assets
-£22.9M
Working capital
Current Assets
£101.5M
Current Liabilities
£124.4M
Fixed Assets
£10.9M
Debtors
£64.3M
Cost of Sales
£82.4M
Gross Profit
-£6.0M
Admin Expenses
£3.2M
Operating Profit
-£9.1M
Profit After Tax
-£200k
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2022 | 0.82 | -£9.2M |
| 2021 | 0.87 | — |
Derived from filed accounts. Not audited figures.